Targeted Therapy for Colorectal Cancer
On this page
- EGFR inhibitors(e.g., cetuximab, panitumumab) used particularly in RAS wild-type tumors
- VEGF inhibitors(e.g., bevacizumab) that inhibit tumor blood vessel growth
- BRAF inhibitors(e.g., encorafenib combined with cetuximab) in specific mutated cases
- Emerging therapiestargeting HER2 amplification and immune checkpoints
Combination with chemotherapy regimens is common to improve effectiveness.
When Targeted Therapy is Indicated
- Alongside chemotherapymainly for advanced or metastatic colorectal cancer, to help people live longer1
- For locally advanced or metastatic colorectal cancerespecially when molecular testing identifies actionable genetic mutations.
Treatment Process
Targeted therapy is generally administered intravenously in outpatient settings across several sessions over weeks to months. The procedure is usually painless and commonly given alongside chemotherapy or immunotherapy.

Talk to experts. Understand your reports. Get a personalized diet plan — all free to start.
Benefits and Risks
Targeted drugs can help some people with advanced colorectal cancer live longer. They act on specific changes in the cancer cells and often have different side effects from chemotherapy.1 Side effects can include rash, diarrhea, fatigue, hypertension, and infusion reactions; these are drug-specific and manageable with care.
Aftercare and Recovery
Post-treatment care entails monitoring side effects, routine follow-ups to assess response, and supportive lifestyle modifications. Prompt communication with the care team about new symptoms is vital.
Why Choose Everhope
Everhope Oncology offers advanced colorectal cancer targeted therapies with expert oncologists, cutting-edge genetic profiling, personalized treatment plans, access to newest approved agents, comprehensive education, and ongoing patient support.
Common questions
What is targeted therapy for colorectal cancer?
Drugs that target specific genetic mutations or proteins in cancer cells to halt growth.
Types of targeted therapies?
EGFR, VEGF, BRAF inhibitors and newer agents.
Cost of targeted therapy?
Varies by drug, regimen, and location; insurance and government aid can reduce costs.
Side effects?
Skin issues, diarrhea, fatigue, hypertension, usually less severe than chemotherapy.
How does the procedure work?
Typically given intravenously in sessions over weeks-months.
Benefits?
Can help some people with advanced cancer live longer, with side effects that differ from chemotherapy.1
Are advanced therapies available?
Yes, ongoing research brings new combination and ligand-targeted therapies.
